Status:
UNKNOWN
Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Non-small Cell Lung Cancer
Lung Function Decreased
Eligibility:
All Genders
20-99 years
Phase:
NA
Brief Summary
A novel nonintubated thoracoscopic technique is promising to enhance recovery after thoracic surgery. However, the effects of nonintubated technique on specific organ protection in not clear yet. In t...
Detailed Description
Lung cancer is the leading cause of cancer-related death worldwide. Its incidence is increasingly arising recently. For early-stage non-small cell lung cancer, surgery is the standard treatment that o...
Eligibility Criteria
Inclusion
- Inclusion criteria
- adults (\> 20 year-old), lung cancer patients undergoing thoracoscopic lobectomy
- Exclusion criteria
- obesity (BMI \> 26 kg/m2)
- previous ipsilateral thoracic surgery
- severe ventilatory insufficiency (oxygen/BiPAP user)
- poor cardiopulmonary function (preop forced expiratory volume at one second (FEV1) \<60%, preop left ventricular ejection fraction \< 50%)
- autoimmune disease requiring chronic steroids
- patients with difficult airway management, pregnant women
Exclusion
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT03471884
Start Date
March 1 2018
End Date
December 31 2018
Last Update
March 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100